Biomedical subjects
V Glaser
Publications and source records attributed to V Glaser.
Geron issued UK Dolly patents.
Explore the source record for details and available documents.
Cloned cows turn back the cellular clock.
Explore the source record for details and available documents.
Genentech relaunched with independence intact.
Explore the source record for details and available documents.
Sugen's strategy: a signal for P&U purchase.
Explore the source record for details and available documents.
Competition between flu drugs feverishly anticipated.
Explore the source record for details and available documents.
Billion-dollar market blossoms as botanicals take root.
Explore the source record for details and available documents.
Neuraminidase inhibitors take bite out of influenza.
Explore the source record for details and available documents.
DPI delivers biotechnology superstore. Discovery Partners International.
Explore the source record for details and available documents.
Myriad's lifestyle test targets borderline hypertensives.
Explore the source record for details and available documents.
Before anyone knew the future nature of biotechnology.
Explore the source record for details and available documents.
Salmonella and rivals PREEMPTed from chickens.
Explore the source record for details and available documents.
PE/TIGR provokes genome sequencing skeptics.
Explore the source record for details and available documents.
Fake blood market gets hemoglobin transfusion from reticulocytes.
Explore the source record for details and available documents.
Anti-inflammatory inflames Centocor's profits.
Explore the source record for details and available documents.
Mutation in ntrC gene leading to the derepression of nitrogenase synthesis in Rhodobacter sphaeroides.
The Rhodobacter sphaeroides mutants Drn12 and Drn21 derepressed for nitrogenase synthesis in the presence of ammonia and impaired in utilization of certain nitrogen sources have been analyzed. Both mutants show a low level of expression of the glnBA operon. The DNA fragment restoring the wild-type phenotype to these mutants contains the 3'-portion of ntrB gene and the entire ntrC gene. Sequence analysis showed that Drn12 bears a missense mutation in the ntrC gene. The mutation results in the replacement of a glycine residue by aspartate within the N-terminal domain of the NtrC protein. Pleiotropic phenotypes of Drn12 and Drn21 appear to be associated with an alteration in the regulation of glnBA expression.
Novartis licenses gene therapy to avoid monopoly.
Explore the source record for details and available documents.
"Ganske" threatens biotechnology patents worldwide.
Explore the source record for details and available documents.